Daily Archive: January 26, 2021

New data show treatment with etesevimab (JS016) and bamlanivimab together reduced risk of COVID-19 hospitalizations and death by 70 percent

Trial met primary endpoint and key secondary endpoints with high statistical significance Results from more than 1,000 high-risk patients were consistent with previous data In November, Lilly submitted a EUA request to the FDA for etesevimab and bamlanivimab together for mild to moderate COVID-19 in high-risk patients, which remains under review by the FDA Findings […]

S. Korean Bond Yields on Jan. 26, 2021

Today (%) Previous Session(%) Change (BP) 1-year TB 0.688 0.689 -0.1 3-year TB 1.007 1.006 +0.1 10-year TB 1.770 1.780 -1.0 2-year MSB 0.907 0.906 +0.1 3-year CB (AA-) 2.122...